Major Depressive Disorder: Using the Components of Shared Decision Making in Treatment Planning

Registration Options

Activity Dates: 10/29/2019 - 10/29/2022

Sign in (or create a FREE account) to register or access your existing registrations

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

This application-based case provides the opportunity to study shared decision-making techniques with a patient living with major depressive disorder. The case follows the patient through two encounters over a period of time, and the activity allows for self-assessment throughout the study as participants apply treatment strategies and patient recommendations. Instructional webinars with patient videos and a final examination provide extended value for participants following completion.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Complete the Pre-Test
  • Review Patient Encounter 1 consisting of case and instructional webinar/demonstration
  • Review Patient Encounter 2 consisting of case and instructional webinar/demonstration
  • Complete the examination at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade of 70%.
  • Be notified of your grade and gain access to your exam results and feedback.
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Participants in this course must complete an examination and achieve a score of 70% or greater. Up to two exam attempts are provided to each participant. Successful completion of the course also requires the completion of a course evaluation. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at https://aapp.org/mycpnp/transcript/acpe.

Faculty Information and Disclosures

Lisa Goldstone, MS, PharmD, BCPS, BCPP

View biographical information and disclosures

Learning Objectives

  1. Identify clinical features and treatment issues as applicable to patients with major depressive disorder (MDD).
  2. Evaluate evidence-based data regarding current and novel treatment approaches to address the clinical needs of patients with MDD.
  3. Apply evidence-based findings to the clinical care of patients with MDD.
  4. Tailor individual treatment plans by using components of shared decision making to improve treatment outcomes for patients with MDD who have at least one comorbid mental illness and medication-related problem.

Continuing Education Credit and Disclosures

Activity Dates: 10/29/2019 - 10/29/2022
ACPE Contact Hours: 2.25
ACPE Number: 0284-0000-19-065-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

Grant Support

The College of Psychiatric and Neurologic Pharmacists gratefully acknowledges an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck in support of this CPE activity.